Akari Therapeutics Plc's latest layoff filing, on May 7, 2024, states a cut of about 67% of its workforce. Akari Therapeutics Plc trades on Nasdaq as AKTX; it was formerly Celsus Therapeutics Plc. As of November 15, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05 (Form 8-K, May 7, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Akari Therapeutics Plc.
Free to see. No signup.
People from Akari Therapeutics Plc who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Akari Therapeutics Plc layoff? Add yourself to the open-to-work list, free
Your entry
Akari Therapeutics Plc reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Akari Therapeutics have layoffs in 2024? What its filings say
Akari Therapeutics Plc (CIK 1541157) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-05-07
Share of workforce
On May 1, 2024, Akari Therapeutics, Plc (the "Company") began to implement a reduction-in-force of approximately 67% of its total workforce as a result of the recently announced program prioritization under which the Company's HSCT-TMA program was suspended.
Expected charges
The Company currently expects expenses related to the reduction-in-force, consisting primarily of cash severance and termination benefits and related costs, to be in the range of approximately $3.1 million to $3.2 million, which includes approximately $1.6 million of non-cash expenses related to vesting of equity awards.
Akari Therapeutics Plc: every filing and event
Also on the record for Akari Therapeutics Plc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G/A, by MMCAP International Inc. SPC | 0.6% of the class | 5%+ stakes | Source |
| November 12, 2026 | Stake report, Schedule 13G/A, by Bank of Montreal | 0.78% of the class | 5%+ stakes | Source |
| August 12, 2026 | Stake report, Schedule 13G, by Bank of Montreal | 5.71% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by White Lion Capital LLC | 5% of the class | 5%+ stakes | Source |
| June 8, 2026 | Stake report, Schedule 13G, by MMCAP International Inc. SPC | 8% of the class | 5%+ stakes | Source |
| June 3, 2026 | Form D, private offering | $1.83M sold | Form D page | Source |
| March 4, 2026 | Stake report, Schedule 13D/A, by Ray Prudo, M.D. | 8.9% of the class | 5%+ stakes | Source |
| March 4, 2026 | Stake report, Schedule 13D/A, by Samir R. Patel | 10.4% of the class | 5%+ stakes | Source |
| March 4, 2026 | Stake report, Schedule 13G/A, by Hoyoung Huh, M.D., Ph.D. | 18.4% of the class | 5%+ stakes | Source |
| October 24, 2025 | Form D, private offering | $6.25M sold | Form D page | Source |
Keep reading
More on Akari Therapeutics Plc and the records around it.
Akari Therapeutics Plc elsewhere on the record
- 5%+ stake filings Nov 2026
- Company profile and every filing Jun 2026
- Form D filing Jun 2026
- Form D filing Oct 2025
- Who owns it
Companies that share a holder
- White Lion Capital LLC also filed stake reports on 4 other companies: Actelis Networks, Inc. (Jul 2026), CID Holdco, Inc. (Jun 2026), RELIANCE GLOBAL GROUP, INC. (Sep 2025)
- Bank of Montreal also filed stake reports on 51 other companies: nCino, Inc. (Nov 2026), North American Construction Group Ltd. (Nov 2026), Alarm.com Holdings, Inc. (Aug 2026)
- MMCAP International Inc. SPC also filed stake reports on 52 other companies: Cartesian Growth Corp II (Nov 2026), CO2 Energy Transition Corp. (Nov 2026), Inflection Point Acquisition Corp. III (Nov 2026)
Watch Akari Therapeutics Plc
Get an email when Akari Therapeutics Plc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Akari Therapeutics Plc?
Want the whole picture on Akari Therapeutics Plc?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Akari Therapeutics Plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Akari Therapeutics Plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
See all on Akari Therapeutics Plc's page
Tools for this story
Each opens in a new tab, filled in for Akari Therapeutics Plc. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Akari Therapeutics Plc? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/akari-therapeutics